Balchem Corporation to Host Conference Call on Q4 2024 Results
Balchem Corporation's Upcoming Conference Call
Balchem Corporation (NASDAQ: BCPC) is excited to announce a significant event for investors: a conference call set for February 21, 2025, at 11:00 AM Eastern Time (ET). This call will focus on the company's performance in the fourth quarter and for the full year of 2024, allowing stakeholders to gain valuable insights directly from the executive team.
Conference Call Details
On the call, attendees will hear from Ted Harris, the Chairman of the Board, who also serves as President and CEO, along with Martin Bengtsson, the Chief Financial Officer. Their combined expertise and insights will provide clarity on the company’s financial standing, strategies, and outlook.
What to Expect from the Results
The financial results for the fourth quarter and the entire year will be released before the market opens on the day of the conference call. Interested parties can find the press release along with detailed financial exhibits on Balchem's official website, ensuring that all stakeholders are informed ahead of this critical communication.
How to Join the Conference Call
To participate in the call, simply dial the toll-free number, 1-877-407-8289, or for local access, call 1-201-689-8341. It’s recommended that you call in five minutes prior to the call's start time. Those unable to join live will have the opportunity to listen to a replay available approximately three hours after the call ends and accessible until the end of the day on March 7, 2025. For the replay, dial 1-877-660-6853 or use 1-201-612-7415 for local access, ensuring you have the conference ID #13751680 handy.
Get to Know Balchem Corporation
Founded on a commitment to enhancing health and nutrition, Balchem Corporation develops and manufactures specialty ingredients that positively impact the health and well-being of people and animals. The company operates through three distinct segments: Human Nutrition & Health, focusing on food and beverage formulations; Animal Nutrition & Health, which caters to the needs of animal health markets; and Specialty Products, targeting healthcare and micronutrient agricultural sectors with innovative solutions.
Contact Information
For further inquiries, individuals can reach out to Jacqueline Yarmolowicz, Executive Assistant at Balchem Corporation. The team can be contacted by telephone at 845-326-5600, or if you prefer email, you may write to jyarmolowicz@balchem.com.
Frequently Asked Questions
What is the focus of the upcoming conference call?
The call will detail Balchem Corporation's financial results for Q4 and the full year of 2024.
Who will be hosting the conference call?
The call will be hosted by Ted Harris, CEO, and Martin Bengtsson, CFO.
How can I access the financial results?
The financial results will be published on Balchem's website before the market opens on the day of the call.
When is the conference call scheduled?
The conference call is set for February 21, 2025, at 11:00 AM ET.
How can I join the conference call?
You can join the call by dialing 1-877-407-8289 or 1-201-689-8341 locally.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.